Kristal Robert Eugene
- SEC CIK
- 0001893955
No open-market purchases or sales filed in the past year.
Current role at each company
- BRTX BioRestorative Therapies, Inc.Chief Financial Officeras of Feb 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kristal Robert Eugene as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 (view filing) | Jun 15 | Same day | Kristal Robert EugeneChief Financial Officer | PPurchase | +194 | $3.61 | +$700.34 | +2.5%7.99K after | |
| Jun 7, 2022 (view filing) | Jun 7 | Same day | Kristal Robert EugeneChief Financial Officer | PPurchase | +200 | $4.56 | +$912 | +2.6%7.80K after | |
| Apr 11, 2022 (view filing) | Apr 8 | 3 days | Kristal Robert EugeneChief Financial Officer | PPurchase | +7.60K | $5.71 | +$43.4K | New position7.60K after |